Kala Pharmaceuticals company info

What does Kala Pharmaceuticals do?
Kala Pharmaceuticals (NASDAQ:KALA) specializes in developing innovative eye care treatments, particularly focusing on therapies for diseases with significant unmet medical needs. The company works on a range of projects, from early research to advanced clinical trials, aiming to bring groundbreaking solutions to patients suffering from eye conditions worldwide. Key objectives include advancing its pipeline of drug candidates through rigorous testing, securing regulatory approvals, and ultimately improving patient outcomes. With a strong commitment to eye health, Kala Pharmaceuticals is dedicated to making strides in ophthalmic treatment and care.
Kala Pharmaceuticals company media
Company Snapshot

Is Kala Pharmaceuticals a public or private company?


How many people does Kala Pharmaceuticals employ?


What sector is Kala Pharmaceuticals in?

pie chart
Health Care

Where is the head office for Kala Pharmaceuticals?

location pin
Head Office
Watertown, United States

What year was Kala Pharmaceuticals founded?

founded flag
Year Founded
What does Kala Pharmaceuticals specialise in?
/Ocular Therapies /Dry Eye Treatment /Corticosteroid Products /Inflammation Solutions /Post-Surgical Care /Drug Delivery Technology

What are the products and/or services of Kala Pharmaceuticals?

Overview of Kala Pharmaceuticals offerings
EYSUVIS, a corticosteroid for the short-term treatment of the signs and symptoms of dry eye disease.
Pipeline focusing on novel treatments for eye diseases using proprietary mucus-penetrating particle (MPP) technology.
Research on advanced formulations for challenging ocular conditions, aiming to enhance drug delivery and efficacy.
Clinical trials aimed at expanding applications of their technology in ocular disease treatment.
Partnerships for the development and distribution of eye care products and technologies.

Who is in the executive team of Kala Pharmaceuticals?

Kala Pharmaceuticals leadership team
  • Mr. Mark T. Iwicki
    Mr. Mark T. Iwicki
    Chairman & CEO
  • Mr. Todd  Bazemore
    Mr. Todd Bazemore
    President & COO
  • Dr. Kim  Brazzell Ph.D.
    Dr. Kim Brazzell Ph.D.
    Head of R&D and Chief Medical Officer
  • Dr. Justin  Hanes Ph.D.
    Dr. Justin Hanes Ph.D.
    Founder & Chair of the Scientific Advisory Board
  • Ms. Mary  Reumuth CPA
    Ms. Mary Reumuth CPA
    CFO & Treasurer
  • Ms. Jill S. Steier
    Ms. Jill S. Steier
    Executive Director of Investor Relations & Corporate Communications
  • Mr. Eric L. Trachtenberg
    Mr. Eric L. Trachtenberg
    Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
  • Mr. Vincent  Kosewski
    Mr. Vincent Kosewski
    Senior VP of Manufacturing & Supply Chain Management